Financhill
Back

Innate Pharma SA Stock Predictions

Innate Pharma SA Stock Forecast

  • Is Innate Pharma SA Stock Undervalued?
    The current Innate Pharma SA [IPHA] share price is $1.63. The Score for IPHA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • IPHA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Innate Pharma SA Stock Go Up Next Year?

Data Unavailable

Innate Pharma SA Stock Rating

Data Unavailable

Innate Pharma SA Stock Price History

Is IPHA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
France
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
innate-pharma.com

52-Week Data

52-Week High:
3.15
52-Week Low:
1.29

Prediction Charts

Market Cap:
131.95M
Price in USD:
1.63
Volume:
7.99K
Beta:
0.36

Technical Analysis

SMA50:
1.97
SMA100:
2.09
SMA200:
2.30
52-Wk Change:
-31.51%

Stock Predictions

  • Is Innate Pharma SA stock public?
    Yes, Innate Pharma SA is a publicly traded company.
  • What is the Innate Pharma SA stock quote today?
    The Innate Pharma SA stock price is 1.63 USD today.
  • How to buy Innate Pharma SA stock online?
    You can buy Innate Pharma SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-6 2.06 2.06 2.06 2.06
Nov-7 1.82 1.84 1.85 1.71
Nov-8 1.57 1.84 1.87 1.57
Nov-11 1.69 1.85 2.00 1.68
Nov-12 1.75 1.90 1.91 1.75
Nov-13 1.70 1.68 1.70 1.68
Nov-14 1.65 1.67 1.68 1.62
Nov-15 1.60 1.44 1.66 1.44
Nov-18 1.45 1.53 1.66 1.29
Nov-19 1.55 1.49 1.61 1.48
Nov-20 1.60 1.69 1.70 1.60
Nov-21 1.65 1.70 1.70 1.56
Nov-22 1.60 1.63 1.70 1.54
Nov-25 1.56 1.45 1.57 1.45

Innate Pharma SA Earnings

Data Unavailable

Innate Pharma SA Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.

* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.